A question well put

New England Journal of Medicine

Volumn 360, Issue 14, 2009, Pages 1446-1451

  Reilly, Brendan M ^a   Hart, Peter D ^b,c   Mascarell, Susana ^b,c   Chatrath, Hemant ^b  

^a WEILL CORNELL MEDICAL CENTER   (United States)

^b Division of Medical Toxicology   (United States)

^c RUSH MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ERGOCALCIFEROL; FIBROBLAST GROWTH FACTOR 23; PHOSPHORUS; DIAGNOSTIC AGENT; DRUG DERIVATIVE; FIBROBLAST GROWTH FACTOR; PENTETREOTIDE; SOMATOSTATIN;

ADULT; ARTICLE; CANCER SURGERY; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DEPRESSION; DIET SUPPLEMENTATION; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; HEMANGIOPERICYTOMA; HIP SURGERY; HUMAN; HUMAN TISSUE; HYPERTENSION; HYPOPHOSPHATEMIA; HYSTERECTOMY; INTRAMEDULLARY NAILING; LEG PAIN; LOW BACK PAIN; MUSCLE STRENGTH; OSTEOMALACIA; OSTEOPENIA; PALPATION; PHOSPHATE BLOOD LEVEL; PHYSICAL EXAMINATION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RANGE OF MOTION; STRESS FRACTURE; VITAMIN D DEFICIENCY; WEAKNESS; BLOOD; BONE TUMOR; DIFFERENTIAL DIAGNOSIS; FEMUR FRACTURE; LEG; METABOLIC BONE DISEASE; MIDDLE AGED; PAIN; PATHOLOGY; RADIOGRAPHY; RIB; RIB FRACTURE; SCINTISCANNING;

BONE DISEASES, METABOLIC; BONE NEOPLASMS; DIAGNOSIS, DIFFERENTIAL; FEMALE; FEMORAL FRACTURES; FIBROBLAST GROWTH FACTORS; FRACTURE FIXATION, INTRAMEDULLARY; HEMANGIOPERICYTOMA; HUMANS; HYPOPHOSPHATEMIA; LEG; MIDDLE AGED; OSTEOMALACIA; PAIN; PHOSPHORUS; RIB FRACTURES; RIBS; SOMATOSTATIN;

EID: 63849228504     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMcps0806165     Document Type: Article

References (15)

1. McCance RA. Osteomalacia with Looser's nodes (Milkman's syndrome) due to a raised resistance to vitamin D acquired about the age 15 years. Q J Med 1947;16:33-46.
2. Jan de Beur SM, Levine MA. Molecular pathogenesis of hypophosphatemic rickets. J Clin Endocrinol Metab 2002;87:2467-2473 (Pubitemid 34655302)
3. Lorenz-Depierieux B, Bastepe M, Benet-Pagès A, et al. DMP1 mutations in autosomal recessive hypophosphatemia implicate a bone matrix protein in the regulation of phosphate homeostasis. Nat Genet 2006;38:1248-1250 (Pubitemid 44646286)
4. Kumar R. Tumor-induced osteomalacia and the regulation of phosphate homeostasis. Bone 2000;27:333-338 (Pubitemid 30658113)
5. Schiavi SC, Moe OW. Phosphatonins: a new class of phosphate-regulating proteins. Curr Opin Nephrol Hypertens 2002;11:423-430
6. Jonsson KB, Zahradnik R, Larsson T, et al. Fibroblast growth factor 23 in oncogenic osteomalacia and X-linked hypophosphataemia. N Engl J Med 2003;348:1656-1663 (Pubitemid 36459471)
7. Shimada T, Muto T, Urakawa I, et al. Mutant FGF-23 responsible for autosomal dominant hypophosphataemic rickets is resistant to proteolytic cleavage and causes hypophosphataemia in vivo. Endocrinology 2002;143:3179-3182
8. Cai Q, Hodgson SF, Kao PC, et al. Inhibition of renal phosphate transport by a tumor product in a patient with oncogenic osteomalacia. N Engl J Med 1994;330:1645-1649 (Pubitemid 24166865)
9. Shimada T, Mizutani S, Muto T, et al. Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia. Proc Natl Acad Sci U S A 2001;98:6500-6505 (Pubitemid 32488266)
10. Jan de Beur SM. Tumor induced osteomalacia. JAMA 2005;294:1260-1267
11. Sommer S, Berndt T, Craig T, Kumar R. The phosphatonins and the regulation of phosphate transport and vitamin D metabolism. J Steroid Biochem Mol Biol 2007;103:497-503. (Pubitemid 46401278)
12. Hsu C. FGF-23 and outcomes research - when physiology meets epidemiology. N Engl J Med 2008;359:640-642
13. Levi M, Bruesegem S. Renal phosphate- transporter regulatory proteins and nephrolithiasis. N Engl J Med 2008;359:1171-1173
14. Schon DA. The reflective practitioner: how professionals think in action. New York: Basic Books, 1983.
15. Dewey J. How we think. Boston: D.C. Heath, 1910.